価格表

在庫・価格 : 2025年04月30日 03時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-A20/TNFAIP3, Mouse-Mono(59A426)
データシート※最新のデータシートでない場合があります
NBP1-77533SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥41,000
(未発注)
追加

在庫・価格 : 2025年04月30日 03時57分 現在

Anti-A20/TNFAIP3, Mouse-Mono(59A426)

  • 商品コード:NBP1-77533SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 De A et al. The deubiquitinase activity of A20 is dispensable for NF-κB signaling. EMBO Rep. 2014 Jul;15(7):775-83
De A et al
2014/01/01
Species: Mouse, Applications: WB PubMed
2 Perez C et al. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts. Int. J. Cancer 2014 Dec;
Perez C et al
2014/01/01
Species: Mouse, Applications: WB PubMed
3 Metellus P et al. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. Cancer 2009 Oct;115(20):4783-94
Metellus P et al
2009/01/01
Applications: PubMed
4 Svingerud T et al. Atlantic salmon type I IFN subtypes show differences in antiviral activity and cell-dependent expression: evidence for high IFNb/IFNc-producing cells in fish lymphoid tissues. J. Immunol. 2012 Dec;189(12):5912-23
Svingerud T et al
2012/01/01
Applications: PubMed
5 Breckpot K et al. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine. J. Immunol. 2009 Jan;182(2):860-70
Breckpot K et al
2009/01/01
Applications: PubMed
6 Frenzel LP et al. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. Int. J. Cancer 2011 May;128(10):2495-500
Frenzel LP et al
2011/01/01
Applications: PubMed
7 Bohgaki M et al. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim. Biophys. Acta 2008 May;1783(5):826-37
Bohgaki M et al
2008/01/01
Applications: PubMed
8 Werner SL et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev. 2008 Aug;22(15):2093-101
Werner SL et al
2008/01/01
Applications: PubMed
9 Harada Y et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010 Jul;70(14):5829-39
Harada Y et al
2010/01/01
Applications: PubMed
10 Karube K et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011 Sep;118(12):3195-204
Karube K et al
2011/01/01
Applications: PubMed
11 Ke B et al. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am. J. Transplant. 2003 Sep;3(9):1076-82
Ke B et al
2003/01/01
Applications: PubMed
12 Ke B et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum. Gene Ther. 2002 Oct;13(15):1845-57
Ke B et al
2002/01/01
Applications: PubMed
13 Yokota S et al. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J. 2008 Jan;22(1):74-83
Yokota S et al
2008/01/01
Applications: PubMed
14 Zhang B et al. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation. Chin. Med. J. 2007 Oct;120(20):1830-5
Zhang B et al
2007/01/01
Applications: PubMed
15 Hutti JE et al. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell. Biol. 2007 Nov;27(21):7451-61
Hutti JE et al
2007/01/01
Applications: PubMed
16 Coornaert B et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 2008 Mar;9(3):263-71
Coornaert B et al
2008/01/01
Applications: PubMed
17 Hailfinger S et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 2009 Nov;106(47):19946-51
Hailfinger S et al
2009/01/01
Applications: PubMed
18 H旦velmeyer N et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur. J. Immunol. 2011 Mar;41(3):595-601
H旦velmeyer N et al
2011/01/01
Applications: PubMed
19 Imbeault M et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J. Virol. 2011 Mar;85(5):2189-200
Imbeault M et al
2011/01/01
Applications: PubMed
20 Wang YY et al. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 2004 Oct;576(1-2):86-90
Wang YY et al
2004/01/01
Applications: PubMed
21 Schmitz R et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J. Exp. Med. 2009 May;206(5):981-9
Schmitz R et al
2009/01/01
Applications: PubMed
22 D端wel M et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J. Immunol. 2009 Jun;182(12):7718-28
D端wel M et al
2009/01/01
Applications: PubMed
23 Li L et al. Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim. Biophys. Acta 2008 Jun;1783(6):1140-9
Li L et al
2008/01/01
PubMed
24 Honma K et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009 Sep;114(12):2467-75
Honma K et al
2009/01/01
PubMed
25 Verhelst K et al. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation. Methods Mol. Biol. 2009;517:205-15
Verhelst K et al
2009/01/01
PubMed
26 Adrianto I et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet. 2011 Mar;43(3):253-8
Adrianto I et al
2011/01/01
PubMed
27 Chevillard G et al. Identification of interleukin-1beta regulated genes in uterine smooth muscle cells. Reproduction 2007 Dec;134(6):811-22
Chevillard G et al
2007/01/01
PubMed
28 Kupfner JG et al. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J. Immunol. 2001 Dec;167(12):7044-51
Kupfner JG et al
2001/01/01
PubMed
29 Salaun B et al. Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin. Cancer Res. 2007 Aug;13(15 Pt 1):4565-74
Salaun B et al
2007/01/01
PubMed
30 Li L et al. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim. Biophys. Acta 2009 Feb;1793(2):346-53
Li L et al
2009/01/01
PubMed
31 Gerlach B et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011 Mar;471(7340):591-6
Gerlach B et al
2011/01/01
PubMed
32 Yang KY et al. Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis. Cell. Signal. 2003 Feb;15(2):225-33
Yang KY et al
2003/01/01
PubMed
33 Malinverni C et al. Cleavage by MALT1 induces cytosolic release of A20. Biochem. Biophys. Res. Commun. 2010 Oct;400(4):543-7
Malinverni C et al
2010/01/01
PubMed
34 Hjelmeland AB et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol. 2010 Feb;8(2):e1000319
Hjelmeland AB et al
2010/01/01
PubMed
35 Wu WS et al. The promyelocytic leukemia protein represses A20-mediated transcription. J. Biol. Chem. 2002 Aug;277(35):31734-9
Wu WS et al
2002/01/01
PubMed
  • No.: 1
  • 文献情報:
    De A et al. The deubiquitinase activity of A20 is dispensable for NF-κB signaling. EMBO Rep. 2014 Jul;15(7):775-83
    De A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Perez C et al. Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts. Int. J. Cancer 2014 Dec;
    Perez C et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Metellus P et al. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. Cancer 2009 Oct;115(20):4783-94
    Metellus P et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Svingerud T et al. Atlantic salmon type I IFN subtypes show differences in antiviral activity and cell-dependent expression: evidence for high IFNb/IFNc-producing cells in fish lymphoid tissues. J. Immunol. 2012 Dec;189(12):5912-23
    Svingerud T et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Breckpot K et al. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine. J. Immunol. 2009 Jan;182(2):860-70
    Breckpot K et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Frenzel LP et al. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. Int. J. Cancer 2011 May;128(10):2495-500
    Frenzel LP et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Bohgaki M et al. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim. Biophys. Acta 2008 May;1783(5):826-37
    Bohgaki M et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Werner SL et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev. 2008 Aug;22(15):2093-101
    Werner SL et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Harada Y et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 2010 Jul;70(14):5829-39
    Harada Y et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Karube K et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011 Sep;118(12):3195-204
    Karube K et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Ke B et al. Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am. J. Transplant. 2003 Sep;3(9):1076-82
    Ke B et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ke B et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum. Gene Ther. 2002 Oct;13(15):1845-57
    Ke B et al
    2002/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Yokota S et al. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J. 2008 Jan;22(1):74-83
    Yokota S et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Zhang B et al. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation. Chin. Med. J. 2007 Oct;120(20):1830-5
    Zhang B et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Hutti JE et al. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell. Biol. 2007 Nov;27(21):7451-61
    Hutti JE et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Coornaert B et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 2008 Mar;9(3):263-71
    Coornaert B et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Hailfinger S et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 2009 Nov;106(47):19946-51
    Hailfinger S et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    H旦velmeyer N et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur. J. Immunol. 2011 Mar;41(3):595-601
    H旦velmeyer N et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Imbeault M et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J. Virol. 2011 Mar;85(5):2189-200
    Imbeault M et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wang YY et al. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 2004 Oct;576(1-2):86-90
    Wang YY et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Schmitz R et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J. Exp. Med. 2009 May;206(5):981-9
    Schmitz R et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    D端wel M et al. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J. Immunol. 2009 Jun;182(12):7718-28
    D端wel M et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Li L et al. Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim. Biophys. Acta 2008 Jun;1783(6):1140-9
    Li L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Honma K et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009 Sep;114(12):2467-75
    Honma K et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Verhelst K et al. Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation. Methods Mol. Biol. 2009;517:205-15
    Verhelst K et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Adrianto I et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet. 2011 Mar;43(3):253-8
    Adrianto I et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Chevillard G et al. Identification of interleukin-1beta regulated genes in uterine smooth muscle cells. Reproduction 2007 Dec;134(6):811-22
    Chevillard G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Kupfner JG et al. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis. J. Immunol. 2001 Dec;167(12):7044-51
    Kupfner JG et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Salaun B et al. Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin. Cancer Res. 2007 Aug;13(15 Pt 1):4565-74
    Salaun B et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Li L et al. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim. Biophys. Acta 2009 Feb;1793(2):346-53
    Li L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Gerlach B et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011 Mar;471(7340):591-6
    Gerlach B et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Yang KY et al. Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis. Cell. Signal. 2003 Feb;15(2):225-33
    Yang KY et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Malinverni C et al. Cleavage by MALT1 induces cytosolic release of A20. Biochem. Biophys. Res. Commun. 2010 Oct;400(4):543-7
    Malinverni C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Hjelmeland AB et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol. 2010 Feb;8(2):e1000319
    Hjelmeland AB et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Wu WS et al. The promyelocytic leukemia protein represses A20-mediated transcription. J. Biol. Chem. 2002 Aug;277(35):31734-9
    Wu WS et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed